Wir verwenden Cookies und Analyse-Tools, um die Nutzerfreundlichkeit der Internet-Seite zu verbessern und für Marketingzwecke. Wenn Sie fortfahren, diese Seite zu verwenden, nehmen wir an, dass Sie damit einverstanden sind. Zur Datenschutzerklärung.
Computational discovery of Natural Drugs against Tuberculosis
Details
Drug design is necessary due to prevalence of multi drug resistant Tuberculosis, HIV co-infection and lack of patient compliance with the chemotherapy and inconsistent efficacy of BCG vaccine. Tuberculosis Research Centre, Chennai has published data on the prevalence of new TB cases which showed that the gradual raise in the prevalence of resistance for the drugs. Hence there is an urgent need to identify more potent and selective antituberculosis drugs that inhibit essential biosynthetic pathways of the bacterium.Natural products have taken a secondary role in drug discovery and drug development, after the advent of molecular biology and combinatorial chemistry made possible the rational design of chemical compounds to target specific molecules. Hence we used natural compounds as a basis for drug development. Hope our study will hold much promise for the development of new therapies against devastating tuberculosis.
Autorentext
Dr.RadhaMahendran,HOD,Department of Bioinformatics,Vels University,Chennai,India.Her major area of research includes Bioinformatics,Microbiology & Genetics.She has published many articles in reputed journals.
Weitere Informationen
- Allgemeine Informationen
- GTIN 09783659783173
- Sprache Englisch
- Genre Medical Books
- Größe H220mm x B150mm x T8mm
- Jahr 2015
- EAN 9783659783173
- Format Kartonierter Einband
- ISBN 365978317X
- Veröffentlichung 06.10.2015
- Titel Computational discovery of Natural Drugs against Tuberculosis
- Autor S. Radhamahendran , J. Suganya , A. Agnal Vincent Paul
- Untertitel Computational screening of Tuberculosis drugs:Bioinformatics Approach
- Gewicht 179g
- Herausgeber LAP LAMBERT Academic Publishing
- Anzahl Seiten 108